HDAC6 and carcinoma: Accordingly, LBH589 (Panobinostat), an inhibitor of histone deacetylase 6 (HDAC6), was used to inhibit the HSP90 activity in cells of several carcinoma cell lines that became radiosensitized in such a way [184].